HemostOD

About HemostOD

HemostOD is a Swiss-based preclinical biotech company founded in 2020, located at the EPFL Innovation Park in Lausanne, Switzerland. The company focuses on engineering and manufacturing universal platelets using a proprietary platform to address critical medical needs and save lives through innovative platelet biology applications.

Products & Services

Thrombocytopenia Treatment:Developing universal platelets for patients with or at risk of HLA immune-refractoriness.

Tissue-Targeted Cargo Delivery (CAR-PLT):Using CAR-PLT technology for shielded delivery of miRNA/siRNA or proteins to specific target tissues.

Regenerative Medicine:Utilizing engineered platelets for wound healing, anti-inflammatory, and immunomodulating applications.

Culture of Therapeutic Stem Cells:Using platelet lysate from universal platelets to enhance cell proliferation.

Universal platelets (HLA-low engineered)

CAR-PLT technology for targeted miRNA/siRNA or protein delivery

Platelet lysate for stem cell culture

Specialties

Platelet Engineering Platelet Manufacturing Thrombocytopenia Treatment Tissue-Targeted Cargo Delivery Regenerative Medicine Stem Cell Culture Molecular & Cell Biology Advanced Microfluidic Technologies Thrombocytopenia treatment (HLA immune-refractoriness) Tissue-targeted cargo delivery Regenerative medicine (wound healing, anti-inflammatory, immunomodulating) In vitro platelet manufacturing platform Megakaryocyte cell line engineering and microfluidic bioreactor processing

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Grant T: - FT: Grant	A: 2500000 MR: - FA: CHF 2 million FAN: 2500000	D: 2026-02-03 FD: 2026-02-03	1 investors
2	RT: Seed Extension T: - FT: Seed Extension	A: 4300000 MR: - FA: CHF 4.3 million FAN: 4300000	D: 2025-10-01 FD: 2025-10-01	4 investors

Grant Latest

2026-02-03

$2.5M

1 investor (Pro only)

Seed Extension 2025-10-01

$4.3M

View 1 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

No team data available

Team information is not yet available for this company

Recent News

HemostOD Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised